Phenytoin toxicity due to genetic polymorphism

Neurocritical Care

Volumn 10, Issue 2, 2009, Pages 222-224

  McCluggage, Lauren K ^a   Voils, Stacy A ^b   Bullock, Malcolm Ross ^c  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b University Health System   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Case report; Phenytoin; Phenytoin toxicity; Polymorphism; Traumatic brain injury

Indexed keywords

ALBUMIN; CYTOCHROME P450 2C9; PHENYTOIN; ANTICONVULSIVE AGENT; CYP2C9 PROTEIN, HUMAN; UNSPECIFIC MONOOXYGENASE;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; DRUG BLOOD LEVEL; DRUG FEVER; DRUG HALF LIFE; DRUG METABOLISM; DRUG WITHDRAWAL; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERGLYCEMIA; LETHARGY; LOADING DRUG DOSE; PRIORITY JOURNAL; SEIZURE; TRAUMATIC BRAIN INJURY; BRAIN INJURY; EPILEPSY; GENETICS; MIDDLE AGED;

ANTICONVULSANTS; ARYL HYDROCARBON HYDROXYLASES; BRAIN INJURIES; EPILEPSY; FEMALE; HUMANS; MIDDLE AGED; PHENYTOIN; POLYMORPHISM, GENETIC;

EID: 66649121223     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-008-9165-9     Document Type: Article

References (8)

1. UI Schwarz 2003 Clinical relevance of genetic polymorphisms in the human CYP2C9 gene Eur J Clin Invest 33 23 30 10.1046/j.1365-2362.33.s2.6.x 14641553 10.1046/j.1365-2362.33.s2.6.x 1:CAS:528:DC%2BD3sXpvFSntrk%3D (Pubitemid 41704979)
2. CR Lee JA Goldstein JA Pieper 2002 Cytochrome P450 2C9 polymorphisms:a comprehensive review of the in-vitro and human data Pharmacogenetics 12 251 63 10.1097/00008571-200204000-00010 11927841 10.1097/00008571-200204000-00010 1:CAS:528:DC%2BD38XnsFKqsLc%3D (Pubitemid 34596790)
3. Winter ME. Phenytoin. In: Winter ME, editor. Basic Clinical Pharmacokinetics. 3rd ed. Vancouver, WA: Applied Therapeutics; 1994. p. 312-48.
4. CC Hung CJ Lin CC Chen CJ Chang HH Liou 2004 Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms Ther Drug Monit 26 534 40 10.1097/00007691-200410000-00012 15385837 10.1097/00007691-200410000-00012 1:CAS:528:DC%2BD2cXnslelsbo%3D (Pubitemid 39314322)
5. J van der Weide LSW Steijns MJM van Weelden K de Haan 2001 The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement Pharmacogenetics 11 287 91 10.1097/00008571-200106000-00002 11434505 10.1097/00008571-200106000-00002 (Pubitemid 32537401)
6. G Citerio A Nobili L Airoldi R Patorelli A Patruno 2003 Severe intoxication after phenytoin infusion: a preventable pharmacogenetic adverse reaction Neurology 60 1395 6 12707459 1:STN:280:DC%2BD3s7ovVKntA%3D%3D
7. DV Lardizabal HO Luders CA Hovinga BFD Bourgeois 2004 Severe intoxication after phenytoin infusions: a preventable pharmacogenetic adverse reactions Neurology 62 161 10.1159/000080099 14727316 10.1159/000080099 letter to editor (Pubitemid 39452091)
8. H Ninomiya K Mamiya S Matsuo I Ieiri S Higuchi N Tashiro 2000 Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication Ther Drug Monit 22 230 2 10.1097/00007691-200004000-00016 10774639 10.1097/00007691-200004000-00016 1:STN:280:DC%2BD3c3jsVKksA%3D%3D (Pubitemid 30196831)